Prosecution Insights
Prosecution Insights
Tech Center 1700 • Art Units: 1612 1616 1617 1621 1627 1629 1783
This examiner grants 52% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 19189086 | RISANKIZUMAB COMPOSITIONS | Non-Final OA | ABBVIE INC. |
| 18011399 | REDOX-RESPONSIVE NANOPARTICLE COMPOSITIONS FOR OCULAR DELIVERY OF THERAPEUTICS | Final Rejection | OHIO STATE INNOVATION FOUNDATION |
| 17760990 | HIGH DENSITY LIPOPROTEIN-LIKE NANOPARTICLES AS INDUCERS OF FERROPTOSIS IN CANCER | Non-Final OA | Northwestern University |
| 18133784 | COMPOSITIONS AND METHODS FOR LOWERING INTRACRANIAL PRESSURE | Non-Final OA | THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE |
| 17849545 | BIOMIMETIC POLYMERIC COMPOSITE FOR HEART VALVE REPAIR | Non-Final OA | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK |
| 18713218 | COSMETIC WATER-IN-OIL EMULSION COMPRISING A SPECIFIC WATER-SOLUBLE UV SCREENING AGENT, A BASE, A VOLATILE OIL, A HYDROPHOBIC FILM-FORMING POLYMER, A POLYOXYALKYLENATED LINEAR POLYDIMETHYLMETHYLSILOXANE AND A VITAMIN B3 | Non-Final OA | L'OREAL |
| 18281381 | COSMETIC SKIN CARE COMPOSITION | Final Rejection | Conopco, Inc., d/b/a UNILEVER |
| 18836055 | CLEAR HAIR STYLING FORMULATION | Non-Final OA | Rohm and Haas Company |
| 17909601 | STABILIZATION OF COMPOUNDS AS CYCLODEXTRIN COMPLEXES | Non-Final OA | University of Pittsburgh - Of the Commonwealth System of Higher Education |
| 18692074 | MULTIPARTICULATE DOSAGE FORMS COMPRISING DEUTETRABENAZINE | Non-Final OA | AUSPEX PHARMACEUTICALS, INC. |
| 17503581 | CONJUGATES OF AUXIN ANALOGS | Final Rejection | Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. |
| 17763010 | SEED COATING COMPOSITIONS | Non-Final OA | CORN PRODUCTS DEVELOPMENT, INC. |
| 17796843 | USE OF POLYETHER COMPOUND | Non-Final OA | Senju Pharmaceutical Co., Ltd. |
| 17907953 | NEW USE AND METHOD OF TREATMENT | Non-Final OA | HUNTER CAPITAL AB (PUBL) |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy